Conclusions: IBD and FL have similar perioperative results. IBD require longer procedural time and greater contrast medium volume, however they are associated with lower IC after 4-year follow-up.
Conclusions:
In this wide real-world experience, long-term results of endovascular treatment of aorto-iliac aneurysms with IBD are favorable, with a low rate of late failure. No significant differences in clinical outcomes were observed in patients receiving balloon-expandable, vs selfexpandable bridging stents or endovascular relining. Objectives: To compare short-term outcomes in patients who underwent endovascular repair with stent grafts alone or with a composite device design (stent grafts plus a bare metal aortic stent) for acute, type B aortic dissection in the setting of malperfusion.
Methods: This retrospective analysis included patients with acute (within 14 days of symptom onset) complicated type B dissection in the setting of malperfusion, who were treated with stent grafts alone (TEVAR cohort) at two European institutions versus those who underwent TEVAR with the Zenith Dissection Endovascular System (Cook Medical, Bloomington, Ind) in the investigational STABLE I feasibility study (of a first-generation device) and STABLE II pivotal study (STABLE cohort). Preoperative characteristics and 30-day outcomes (including mortality, morbidity, and secondary interventions) were compared between the two groups.
Results: The TEVAR cohort (41 patients, mean age 59 6 13 years, 78% male) and the STABLE cohort (84 patients, mean age 58 6 12 years, 71% male) were largely similar in preoperative medical characteristics, with more STABLE patients presenting a history of hypertension (80% vs 59%; P ¼ .018). The TEVAR and STABLE groups had similar lengths of dissection (451.8 6 112.7 mm vs 411.8 6 116.4 mm; P ¼ .10) and similar proximal and distal extent of dissection. At presentation, the two groups exhibited comparable organ system involvement in malperfusion: renal (54% TEVAR, 57% STABLE), gastrointestinal (42% TEVAR, 44% STABLE), lower extremities (34% TEVAR, 52% STABLE), and spinal cord (10% TEVAR, 2.4% STABLE). The 30-day rate of all-cause mortality was 17% (7 of 41) in the TEVAR group and 8.3% (7 of 84) in the STABLE group (P ¼ .22). The 30-day rate of malperfusion-related mortality (deaths from bowel/mesenteric ischemia or multiple organ failure) was 12% (5 of 41) in the TEVAR group and 2.4% (2 of 84) in the STABLE group (P ¼ .038). Thirty-day morbidity, for the TEVAR and STABLE groups, respectively, included bowel ischemia (9.8%, 4 of 41 vs 2.4%, 2 of 84; P ¼ .09), renal failure requiring dialysis (7.3%, 3 of 41 vs 9.5%, 8 of 84; P > .99), paraplegia or paraparesis (4.9%, 2 of 41 vs 3.6%, 3 of 84; P ¼ .66), and stroke (2.4%, 1 of 41 vs 11%, 9 of 84; P ¼ .16). The occurrence of 30-day secondary intervention was similar in the TEVAR and STABLE groups (7.3%, 3 of 41 vs 7.1%, 6 of 84; P > .99).
Conclusions: In patients with acute type B aortic dissection in the setting of branch vessel malperfusion, the use of a composite device with proximal stent grafts and distal bare aortic stent seemed to result in lower malperfusion-related mortality than the use of stent grafts alone. Thirty-day rates of morbidity and secondary interventions were similar between the groups. Objectives: To evaluate the effect of proximal seal length on outcomes after endovascular repair of acute Type B aortic dissection (aTBAD).
Methods: This analysis included data from two prospective, multicenter investigational studies of the Zenith Dissection Endovascular System: STABLE I (a feasibility study on the first-generation device including patients treated in both acute and nonacute phases) and STABLE II (a pivotal study including only patients presenting with aTBAD). Patients treated for aTBAD (within 14 days of symptoms onset) were included if they had complete preoperative and postoperative imaging to determine the actual length of proximal seal in uninvolved aorta. This was calculated by recording the difference between the length from the left common carotid artery (LCC) to the most proximal extent of dissection and the length from the LCC to the most proximal 360 visualization of the stent graft. Patients were divided into four groups: 20 mm, 10 mm to <20 mm, 0 mm to <10 mm, and <0 mm of proximal seal length. Outcomes related to proximal seal were evaluated. All imaging findings were based on core laboratory analysis.
Results: This analysis included 110 patients (51 in STABLE I and 59 in STABLE II). While the study protocol criteria required $20 mm length of nondissected aorta distal to the LCC to serve as the proximal seal zone, an actual proximal seal length of 20 mm was achieved in only 17.3% of patients (19 of 110). At the time of this analysis (mean follow-up of 39.6 6 20.4 months), the incidences of any proximal type I entry flow, retrograde dissection, transaortic growth 5 mm in the thoracic aorta, and stent graft migration 10 mm in the four groups are shown in the Table. The combined rate of these complications was lowest (15.8%, 3 of 19) for patients with 20 mm proximal seal and increased as the seal length decreased, as shown in Fig Objectives: Duty-hour restrictions, changing training paradigms, and diminishing open surgical case volumes have caused dramatic shifts in vascular trainees experience over the past decade. While simulation training has been advocated as an augment to resident training, the benefits of short 3-to 4-day courses are largely unknown. The goal of this study was to perform a 6-year review of the first simulation course established for vascular trainees in the United States.
Methods: A 3-day vascular simulation course was conducted at a dedicated learning center each year from 2012 to 2017. Attendees rated their confidence pre and post course on a 6-point Likert scale ranging from 1 none to 6 expert across eight different technical and cognitive 
